Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online February 1, 2013.
Article Versions
- You are currently viewing a Latest version of this article (February 1, 2013 - 04:00).
- View the most recent version of this article
Copyright & Usage
© 2013 The Journal of Rheumatology
Author Information
- Michael E. Weinblatt,
- Arthur Kavanaugh,
- Mark C. Genovese,
- David A. Jones,
- Theresa K. Musser,
- Elliott B. Grossbard and
- Daniel B. Magilavy
- From the Division of Rheumatology, Immunology, and Allergy, Brigham and Women’s Hospital, and Harvard Medical School, Boston, Massachusetts; University of California, San Diego, California; Stanford University, Palo Alto, California; AstraZeneca, Macclesfield, UK; and Rigel Pharmaceuticals Inc., South San Francisco, California, USA.
Supported by Rigel Pharmaceuticals Inc. Dr. Weinblatt serves as a consultant to Rigel and AstraZeneca. Dr. Genovese serves as a consultant to Rigel and AstraZeneca and receives grant/research support from Rigel and AstraZeneca. Mr. Jones is an employee of AstraZeneca. Ms. Musser, Dr. Grossbard, and Dr. Magilavy are employees of Rigel.
M.E. Weinblatt, MD, Division of Rheumatology, Immunology, and Allergy, Brigham and Women’s Hospital, and Harvard Medical School; A. Kavanaugh, MD, University of California; M.C. Genovese, MD, Stanford University; D.A. Jones, MSc, AstraZeneca; T.K. Musser, BA; E.B. Grossbard, MD; D.B. Magilavy, MD, Rigel Pharmaceuticals Inc.
Address correspondence to Dr. M.E. Weinblatt, Division of Rheumatology, Immunology, and Allergy, Brigham and Women’s Hospital, 75 Francis Street, Boston, MA 02115, USA. E-mail: MWEINBLATT@PARTNERS.ORG
Accepted for publication December 4, 2012.